Renaissance Technologies - SPRING BK PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of SPRING BK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2020$693,000
-0.3%
517,078
+9.4%
0.00%0.0%
Q2 2020$695,000
+122.0%
472,530
+40.2%
0.00%
Q1 2020$313,000
-1.3%
336,927
+67.7%
0.00%
Q4 2019$317,000
-38.4%
200,930
+34.1%
0.00%
Q3 2019$515,000
+6.4%
149,800
+14.2%
0.00%
Q2 2019$484,000
+25.1%
131,200
+255.6%
0.00%
Q1 2019$387,000
+22.1%
36,900
+21.0%
0.00%
Q4 2018$317,000
-8.6%
30,500
+5.9%
0.00%
Q3 2018$347,000
+88.6%
28,800
+85.8%
0.00%
Q2 2018$184,000
-67.8%
15,500
-54.3%
0.00%
-100.0%
Q3 2017$571,000
+23.6%
33,883
-0.6%
0.00%0.0%
Q2 2017$462,00034,1020.00%
Other shareholders
SPRING BK PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
BVF INC/IL 951,701$9,983,0001.12%
Morse Asset Management, Inc 149,175$1,565,0000.47%
SECTORAL ASSET MANAGEMENT INC 276,656$2,902,0000.35%
PARSONS CAPITAL MANAGEMENT INC/RI 276,963$2,905,0000.32%
CAXTON CORP 23,717$249,0000.23%
TIEDEMANN ADVISORS, LLC 412,049$4,323,0000.20%
Private Capital Advisors, Inc. 52,335$549,0000.17%
Pegasus Asset Management, Inc. 18,750$197,0000.16%
Hikari Power Ltd 53,536$562,0000.06%
SPHERA FUNDS MANAGEMENT LTD. 51,015$535,0000.05%
View complete list of SPRING BK PHARMACEUTICALS IN shareholders